ESR1 and breast cancer: However, recent studies involving over 200000 breast cancer patients shows a statistically significant correlation between increased breast cancer risk and high levels of cholesterol carrier proteins, high- and low-density lipoproteins (HDL and LDL), independently of tumor estrogen receptor status [6–8], suggesting a connection between cholesterol uptake and cancer progression.